Analysing the efficacy of polidocanol in injection snoreplasty

Authors

  • Manjunath K. Department of ENT, Basaveshwara Medical College and Hospital, Research Centre, Chitradurga, Karnataka, India
  • Amardeep Singh Department of ENT, Basaveshwara Medical College and Hospital, Research Centre, Chitradurga, Karnataka, India
  • Manjunatha Rao S. V. Department of ENT, Basaveshwara Medical College and Hospital, Research Centre, Chitradurga, Karnataka, India
  • Akash Aradhya S. Department of ENT, Basaveshwara Medical College and Hospital, Research Centre, Chitradurga, Karnataka, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20200069

Keywords:

Injection snoreplasty, Snoring, Polidocanol

Abstract

Background: Injection snoreplasty was recently introduced as a safe, effective, and minimally invasive treatment for primary snoring. The objective of the study was to assess the effectiveness of the treatment in our patients.

Methods: The study was a prospective, non-randomised study done on 40 patients with primary snoring. Study was done in the Department of Otorhinolaryngology and Head and Neck Surgery at Basaveshwara Medical College and Hospital, Chitradurga over 8 months between March 2019 to October 2019. The data was collected from patients about their symptoms. Detailed clinical and radiological examination was done in all patients. Almost each and every causes of snoring were ruled out. 1-3% polidocanol injection of about 1 ml with insulin syringe was administered in all the patients in 1 to 3 sittings after 10% LOX spray application on the site. Patients were assessed after 1, 3 and 6 months and their improvement was noted.  

Results: There were 24 (60%) males and 16 (40%) females enrolled in our study with mean age as 42±5 years. The average BMI of patients was 27.14±3.1 kg/m2. All the patients except 4 were initially injected 1% polidocanol injection; the others were injected 3%. 4 (10%) patients were re-injected at 1 month and 4 (10%) had 2nd re-injection at 3 months follow up. The mean improvement in symptoms was 58%. Eleven patients (27.5%) had moderate snoring while the rest had severe snoring. The only side effect was pain which in majority of patients was mild. There was no correlation between BMI and percentage of improvement.

Conclusions: Injection snoreplasty is a safe and cost-effective treatment for primary snoring.

References

Hoffstein V, Madeira JH, Mateika S. Snoring and sleep architecture. AM Rev Respir Dis. 1991;143:92-96.

Powel NB, Riley RW, Troell RJ, Li K, Blumen MB, Guilleminault C. Radiofrequency volumetric tissue reduction of the palate in subjects with sleep-disordered breathing, Chest. 1998;113:1163-74.

Mair EA, Day RH. Cautery-assisted palatal stiffening operation. Otolaryngol Head Neck Surg. 2000;122:547-55.

Kamami YV. Outpatient treatment of sleep apnea syndrome with CO2 laser laserassisted UPPP. J Otolaryngol. 1994;23:395-8.

Fujita S, Conway W, Zorick F, Roth T. Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg. 1981;89:923-34.

Levin BC, Becker GD. Uvulopalatopharyngoplasty for snoring long term results. Laryngoscope. 1994;104:1150-2.

Brietzke SE, Mair EA. Injection snoreplasty: How to treat snoring without all the pain and expense. Otolaryngol Head Neck Surg. 2001;124:503-10.

Jaimanti B, Gupta AK, Dash AN, Khandelwal G. Injection Snoreplasty-a simple way to treat habitual snoring. Br J Med Med Res. 2014;4(30):4946-55.

Tsara V, Amfilochiou A, Papagrigorakis MJ, Georgopoulos D, Liolios E. Definition and classification of sleep related breathing disorders in adults. Hippokratia. 2009;13(3):187-91.

Smith S. Reporting the Apnoea Hypopnea Index (AHI). J Clin Sleep Med. 2007;3(3):321.

Brietzke SE, Mair EA. Injection snoreplasty: Extended follow-up and new objective data. Otolaryngol Head Neck Surg. 2003;128:605-15.

Brietzke SE, Mair EA. Injection snoreplasty: Investigation of alternative sclerotherapy agents. Otolaryngol Head Neck Surg. 2004;130:47-57.

Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep. 1996;19:156-77.

Powell NB, Riley RW, Guilleminault C. Radiofrequency tongue base reduction in sleep-disordered breathing: a pilot study. Otolaryngol Head Neck Surg. 1999;120:155-62.

Kezirian EJ, Goldberg AN. Hypopharyngeal surgery in obstructive sleep apnea. Arch Otolaryngol. 2006;132:206-13.

den Herder C, van Tinteren H, de Vries N. Hyoidthryroidpexia: A surgical treatment for sleep apnea. Laryngoscope. 2005;115:740-5.

Labra A, Haro-Valencia R, Huerta-Delgado AD, Correa UJ, Sanchez-Narvaez F. Efficacy of Submucosal Sodium Tetradecyl Sulfate in the Soft Palate as a Treatment of the Mild Obstructive Sleep Apnea Syndrome: A Pilot Study. Sleep Disorders: 2012;2012:597684.

Joachim TM, Hein G, Verse T, Hormann K, Stuck BA. Long-term results of palatal implants for primary snoring. Otolaryngol Head Neck Surg. 2005;133:573-8.

Downloads

Published

2020-01-24

Issue

Section

Original Research Articles